34.95
-0.05 (-0.14%)
-0.05 (-0.14%)
Upgrade to Real-Time
Afterhours
Low
24.00
High
74.89
Best deals to access real time data! |
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
Small Cap Basic
Monthly Subscription
for only
|
Big Cap Pro
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
BioXcel Therapeutics Inc | BTAI | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
-0.05 | -0.14% | 34.95 | 16:06:00 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
35.06 | 34.20 | 35.41 | 34.98 | 35.00 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
34.90 | 35.40 | 0.50 | - | - |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,193 | 261,759 | $ 34.86 | $ 9,126,030 | 574,141 | 24.00 - 74.89 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:01:43 | formt | 6,900 | $ 34.95 | USD |
BioXcel Therapeutics Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 851.67M | 24.37M | 14.67M | $ - | $ - | -2.02 | -14.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | - | - |
BioXcel Therapeutics News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTAI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 36.915 | 37.00 | 33.75 | 35.01 | 351,930 | -1.97 | -5.32% |
1 Month | 45.19 | 47.08 | 33.75 | 39.17 | 585,893 | -10.24 | -22.66% |
3 Months | 47.50 | 67.74 | 33.75 | 47.36 | 545,828 | -12.55 | -26.42% |
6 Months | 51.85 | 67.74 | 33.75 | 48.21 | 509,589 | -16.90 | -32.59% |
1 Year | 24.00 | 74.89 | 24.00 | 47.32 | 543,041 | 10.95 | 45.63% |
3 Years | 9.28 | 74.89 | 2.41 | 36.94 | 285,357 | 25.67 | 276.62% |
5 Years | 11.02 | 74.89 | 2.41 | 36.49 | 280,759 | 23.93 | 217.15% |
BioXcel Therapeutics Description
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701. |